Revelation Biosciences Inc.

REVB | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.96

-$0.02 (-1.67%)

At close: Sep 22, 2026, 3:59 PM ET

$0.93

-$0.03 (-3.10%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-1.67%

(1D)

Rating

Updated: Aug 17, 2026

21.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $3.75M

1D Range

0.96 1.02

52W Range

0.88 6.76

Valuation (TTM)

PE -0.14

PB 0.38

EV/EBITDA 0.64

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -333.5%

SBC Adj. FCF Yield -378.4%

SBC Impact -13.5%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -87.3% | 20.9%

Dil EPS 3Y | 5Y 137.3% | 96.2%

FCF 3Y | 5Y -13.9% | -8.1%

Returns

ROA -86.0%

ROE -100.2%

ROIC -104.3%

Financial Health

Net Cash

$10.74M

Current Ratio 6.21

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Revelation Biosciences, Inc. is a biopharmaceutical firm currently in its clinical development phase, dedicated to the advancement and commercialization of treatments and diagnostic tools targeting th...

Sector Healthcare

Industry Biotechnology

Employees 8

IPO Date Nov 16, 2020

Website www.revbiosciences.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.